Drawing for LIPOCLONAL

USPTO serial 75397566

LIPOCLONAL

Reviewed by CopyMark Law Group

Reg. 2579002Status 710
Filing date
Status date
Registration date
Jun 11, 2002
Examiner
MCMORROW, RONALD G
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LIPOCLONAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN L DUPRE

JOHN L DUPRE HAMILTON BROOK SMITH & REYNOLDS PC530 VIRGINIA RD P O BOX 9133CONCORD, MA 01742-9133UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents, namely, antibodies for scientific diagnostic research purposesSECTION 8 - CANCELLEDFeb 15, 2002
005Pharmaceuticals, namely antibodies for treatment of cardiovascular, hematological, immunological, burn, dermatological, central nervous system, motor neuron, cancerous, gastrointestinal, orthopedic, oncological, inflammatory, infectious, viral, respiratory, asthmatic, allergic, ischemia/reperfusion, metabolic, diabetic, transplant rejection, alopecia, periodontal, ophthalmic, adult respiratory distress, sepsis, and organ failure conditions, diseases, syndromes and disorders; antibodies for in vivo diagnostic purposesSECTION 8 - CANCELLEDFeb 15, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 14, 2009C8..CANCELLED SEC. 8 (6-YR)—
Sep 13, 2007CFITCASE FILE IN TICRS—
Jun 11, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 5, 2002CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 4, 2002DOCKASSIGNED TO EXAMINER—
Mar 1, 2002SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 16, 2002IUAFUSE AMENDMENT FILED—
Aug 14, 2001EX5GSOU EXTENSION 5 GRANTED—
Aug 1, 2001EXT5SOU EXTENSION 5 FILED—
Feb 13, 2001EX4GSOU EXTENSION 4 GRANTED—
Dec 27, 2000EXT4SOU EXTENSION 4 FILED—
Aug 15, 2000EX3GSOU EXTENSION 3 GRANTED—
Jun 20, 2000EXT3SOU EXTENSION 3 FILED—
Mar 27, 2000EX2GSOU EXTENSION 2 GRANTED—
Jan 21, 2000EXT2SOU EXTENSION 2 FILED—
Aug 16, 1999EX1GSOU EXTENSION 1 GRANTED—
Aug 16, 1999EXT1SOU EXTENSION 1 FILED—
Feb 16, 1999NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 24, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 1998NPUBNOTICE OF PUBLICATION—
Jul 28, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance